Lord Global Corp. engages in developing, producing & distributing fictional and documentary films. The company is headquartered in Carson City, Nevada. The company went IPO on 2016-06-28. 27Health Inc. is focused on financing and marketing, healthcare-related products. The firm distributes the Virolens product in Asia, Australia, New Zealand and other Oceania countries. The Virolens system is a COVID-19 screening device based on microscopic holographic imaging and artificial intelligence (AI) software technology. The company uses a digital camera attached to a microscope to analyze saliva samples, with the data run through a computer that is trained to identify the virus from other cells, delivering a result in just 20 seconds. The Virolens system was trained to recognize the COVID-19 virus particles in saliva using a range of samples of COVID-19 virus provided by virologists working on the virus at the University of Bristol.
根据最新的财务报表(Form-10K),27 Health Holdings Corp 的总资产为 $0,净亏损为 $0
LRDG 的关键财务比率是什么?
27 Health Holdings Corp 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
27 Health Holdings Corp 的收入按细分市场或地理位置如何划分?
27 Health Holdings Corp 最大收入来源是 Banking and Related Activities,在最近的收益报告中收入为 1,515,219,000。就地区而言, United States 是 27 Health Holdings Corp 的主要市场,收入为 1,515,219,000。